Cargando…
Potential inhibitors interacting in Neuropilin-1 to develop an adjuvant drug against COVID-19, by molecular docking
The COVID-19 pandemic continues without specific treatment. In this study it is proposed compounds that can be developed as adjuvant / complementary drugs against COVID-19. Through a search for molecular docking, for the development of a new drug using pharmacological compounds targeting the b1 regi...
Autor principal: | Vique-Sánchez, José Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826060/ https://www.ncbi.nlm.nih.gov/pubmed/33515918 http://dx.doi.org/10.1016/j.bmc.2021.116040 |
Ejemplares similares
-
Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug
por: Benítez-Cardoza, Claudia Guadalupe, et al.
Publicado: (2020) -
Computational screening of potential drugs against COVID-19 disease: the Neuropilin-1 receptor as molecular target
por: Charoute, Hicham, et al.
Publicado: (2022) -
Computation screening and molecular docking of FDA approved viral protease inhibitors as a potential drug against COVID-19
por: Absalan, Abdorrahim, et al.
Publicado: (2020) -
Molecular Docking of Potential Inhibitors of Broccoli Myrosinase
por: Román, J., et al.
Publicado: (2018) -
Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation
por: Cava, Claudia, et al.
Publicado: (2021)